Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial (Q42878211)
Jump to navigation
Jump to search
scientific article published on October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial |
scientific article published on October 2010 |
Statements
1 reference
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial (English)
1 reference
1 reference
1 reference
1 reference
Finn Wisløff
1 reference
Peter Gimsing
1 reference
Kristina Carlson
1 reference
Ingemar Turesson
1 reference
Anders Waage
1 reference
Anne Mylin
1 reference
Gunnar Juliusson
1 reference
Henrik Gregersen
1 reference
Henrik Hjorth-Hansen
1 reference
Ingerid Nesthus
1 reference
Inger Marie S Dahl
1 reference
Jan Westin
1 reference
Johan Lanng Nielsen
1 reference
Lene Meldgaard Knudsen
1 reference
Lucia Ahlberg
1 reference
Martin Hjorth
1 reference
Niels Abildgaard
1 reference
Niels Frost Andersen
1 reference
Olle Linder
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference